YD Bio Ltd balance sheet

At the end of fiscal 2025, YD Bio Ltd had total assets of $13.8m, total liabilities of $16.6m and shareholders' equity of −$2.9m. It held $6.0m in cash against $6,764 of debt: net cash of $6.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

YD Bio Ltd: balance sheet, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	0	3	6
Receivables	—	0	0
Inventory	—	0	2
Total current assets	—	3	10
Total assets	—	7	14
Accounts payable	—	0	0
Deferred revenue (current)	—	0	0
Total current liabilities	—	0	2
Long-term debt	—	—	0
Total debt	0	0	0
Total liabilities	—	0	17
Shareholders' equity	0	7	−3
Net debt (negative = net cash)	−0	−3	−6
Shares outstanding	—	65m	71m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ISPC vs YDES QSI vs YDES BGLC vs YDES ACON vs YDES

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from YD Bio Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to YD Bio Ltd.